Menu
No results found.
PPGN
PolyPeptide Group AG – SWX
“Patience reduces risk more reliably than prediction.”
Weekly Share Price & Valuation Overview
Market Overview
Open
25.8000
Close
25.8000
High
26.3000
Low
25.6500
Trend
0.66267
PolyPeptide Group AG
Switzerland
• SWX - SIX Swiss Exchange
• PPGN
• Currency: CHF
PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
Key strengths
- Revenue growth ≥10% indicates solid top-line momentum.
Potential weaknesses
- Quick ratio <0.8 — tight near-term liquidity without inventory.
- Debt/EBITDA >4 — elevated leverage vs earnings capacity.
- Negative free cash flow — operations may rely on external financing.
Scale & Structure
Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
- Market Cap Total equity value of the company (share price × shares outstanding).
- CHF 857.78M
- Enterprise Value Operating value: market cap + total debt − cash.
- CHF 892.40M
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- CHF 368.84M
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- CHF 41.52M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- CHF 19.84M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- CHF 11.08
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- -0.98
- Shares Outstanding
- 32.99M
- Float Shares
- 12.93M
- Implied Shares Outstanding
- 32.99M
Profitability & Efficiency
TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
-8.21%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
5.38%
- Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
11.26%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
-9.41%
- ROA Return on assets: net income ÷ total assets.
-
-0.62%
- ROE Return on equity: net income ÷ shareholder equity.
-
-10.05%
Growth
Growth rates are YoY unless labeled QoQ.
- Revenue Growth Strong Year-over-year revenue growth.
-
23.70%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
6.12%
Liquidity & Solvency
Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
- Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).
- 0.73
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.34
- Total Cash Cash and equivalents.
- CHF 76.69M
- Total Debt Short + long-term interest-bearing debt.
- CHF 111.32M
- Net Debt Total debt − cash (negative = net cash).
- CHF 34.62M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 5.61
Cash Flow
Shown only when internally consistent; margins are TTM.
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- CHF 138.58M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- CHF -39.59M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
37.57%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
-10.73%
- Cash Conversion (OpCF/EBITDA)
- 6.98
Sharemaestro House View
Confidence: 1
Sharemaestro internal conviction (0–3, higher is better).
Risk: 2
Sharemaestro internal risk profile (0–3, higher is safer).
Composite Score: 1
Overall internal composite (0–3, higher is better).
Suggested Allocation: 1.67%
Indicative portfolio weighting suggestion based on house view.
Structural Insights
(experimental)
Ownership & Liquidity
Free Float
Proportion of shares available for public trading.
39.2%
Insiders
Shares held by company insiders (officers, directors).
60.5%
Institutions
Shares held by institutions (funds, pensions).
23.8%
Capital Structure
Potential Dilution
Increase in share count if options/convertibles exercise.
None detected
Net Debt
Total debt − cash (negative = net cash).
CHF 34.62M
9.4% of revenue
Net debt relative to revenue — debt load vs business scale.
Resilience Score
0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating.
41
Methodology Notes
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-09-09 12:46
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.
Performance Edge:
Signals that work. Valuations that spot mispricing early. A disciplined, data-driven methodology powered by machine learning. Sharemaestro helps high-net-worth investors, hedge funds, family offices, and institutions move sooner - and with conviction - when the market presents asymmetric opportunity.
Subscribe to Sharemaestro: